253 related articles for article (PubMed ID: 4213282)
1. Outpatient intravenous medications in the management of cystic fibrosis.
Rucker RW; Harrison GM
Pediatrics; 1974 Sep; 54(3):358-60. PubMed ID: 4213282
[No Abstract] [Full Text] [Related]
2. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
3. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
[No Abstract] [Full Text] [Related]
4. [Pathogenesis and diagnosis of bacterial airway infections in patients with cystic fibrosis].
Möller AV; van Alphen L; Dankert-Roelse JE; Dankert J
Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2346-9. PubMed ID: 7501072
[No Abstract] [Full Text] [Related]
5. [Cystic fibrosis: current therapy. Antibiotics].
Tamm M; Héritier F; Rappaz I; Schaad UB
Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
[No Abstract] [Full Text] [Related]
6. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
Eber E; Thalhammer GH; Zach MS
Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
[No Abstract] [Full Text] [Related]
7. Cystic fibrosis: intravenous treatment at home.
Catchpole A
Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
[No Abstract] [Full Text] [Related]
8. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
Châtain P
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
[No Abstract] [Full Text] [Related]
9. Home intravenous therapy using a silastic long line catheter in cystic fibrosis patients.
Pradeepkumar VK; Waseem E; Shortt C; Barry D; Watson JB
Ir Med J; 1992 Sep; 85(3):110-1. PubMed ID: 1399475
[TBL] [Abstract][Full Text] [Related]
10. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
[TBL] [Abstract][Full Text] [Related]
11. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
Conway SP; Etherington C; Munday J; Goldman MH; Strong JJ; Wootton M
Ann Pharmacother; 2000 Nov; 34(11):1238-42. PubMed ID: 11098334
[TBL] [Abstract][Full Text] [Related]
12. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
13. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
Elborn JS; Hodson M; Bertram C
J Cyst Fibros; 2009 May; 8(3):211-7. PubMed ID: 19372063
[TBL] [Abstract][Full Text] [Related]
14. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
15. Editorial overview: clinical utility of synergy testing for multidrug resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Middleton PG
Paediatr Respir Rev; 2007 Sep; 8(3):262-3, quiz 263-4. PubMed ID: 17868925
[No Abstract] [Full Text] [Related]
16. Duration of intravenous antibiotic treatment for respiratory exacerbations in children with cystic fibrosis.
Brown SM; Balfour-Lynn IM
Arch Dis Child; 2010 Jul; 95(7):568. PubMed ID: 20522458
[No Abstract] [Full Text] [Related]
17. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
Foucaud P; Borel B; Charara O; Nathanson S; Petitprez P; Pin I
Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
[TBL] [Abstract][Full Text] [Related]
18. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
Hubert D; Desmazes-Dufeu N; Dusser D
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
[No Abstract] [Full Text] [Related]
19. The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN; Ratjen F
Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
[TBL] [Abstract][Full Text] [Related]
20. [Ochrobactrum anthropi bacteremia in a child with cystic fibrosis].
Yagüe-Muñoz A; Gregori-Roig P; Valls-López S; Pantoja-Martínez J
Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):137-8. PubMed ID: 19811858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
